We aimed to explore neuroendocrine differentiation in meningiomas by investigating the following neuroendocrine markers: neural cell adhesion molecule (CD56/NCAM), chromogranin A, chromogranin B, chromogranin C, neuron-specific enolase (NSE), secretagogin, and synaptophysin. Here, CHL1 is linked to meningioma.